Dose
NMCSD.2016.0039
Phase 3 small_molecule terminated
Quick answer
Dose for Chronic Migraine, Headache is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Chronic Migraine, Headache
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated